Feb 25 2011 0 Dr. Noah Weisleder, Chief Scientific Officer of TRIM-edicine, was awarded the 2011 Kauffman Foundation Postdoctoral Entrepreneur Award. trimedicine This award recognizes entrepreneurial excellence from those with a Ph.D. that completed postdoctoral studies in the USA.Read More
Nov 05 2010 0 TRIM-edicine filed a new provisional patent application on developing new diagnostic biomarkers for tissue injury. trimedicine Read More
Nov 01 2010 0 TRIM-edicine was awarded a Qualifying Therapeutic Project (QTDP) Grant from the US Government for “Treatment of muscular dystrophy by protein therapeutics”. This program will assist in the development of a novel therapy for this unmet medical need. trimedicine Read More
Sep 02 2008 0 TRIM-edicine was awarded a Small Business Innovation & Research (SBIR) Grant for “Protein Therapeutics for Muscular Dystrophy”. Several reports indicate the significance of this award leading to the development of new approaches for genetic muscle disorders. trimedicine Read More
Apr 10 2008 0 TRIM-edicine joins Biotechnology Industry Organization (BIO), the largest biotechnology organization in the world that is dedicated to representing the interests of companies associated with the bioscience industry. trimedicine Read More
Feb 15 2008 0 TRIM-edicine opens a new R&D facility at the Commercialization Center for Innovative Technology in North Brunswick, New Jersey. trimedicine Read More
Dec 04 2007 0 Commission on Science and Technology of New Jersey grants TRIM-edicine $500,000 to develop products in collaboration with the Colgate-Palmolive Co. Furthermore, the NJCST also awarded Christopher Ferrante $130,000 to conduct postdoctoral research at TRIM-edicine. trimedicine Read More
Nov 13 2007 0 TRIM-edicine signs a licensing agreement with UMDNJ-Robert Wood Johnson Medical School to commercialize technology developed in the laboratory of Dr. Jianjie Ma. trimedicine .Read More
